A Multicenter, Open-label Phase 2 Study of Lenvatinib Plus Pembrolizumab in Previously Treated Subjects with Selected Solid Tumors (LEAP-005).

  • Gill, Sanjeev (Primary Chief Investigator (PCI))
  • Cross, Nikki (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date22/03/19 → 31/12/24

Keywords

  • Medical Oncology
  • Solid Tumors
  • Clinical trial